Skip to main content
. 2023 Mar 2;117:109950. doi: 10.1016/j.intimp.2023.109950

Table 1.

Serious Adverse Events, Ta1 Treatment Group.

Patient Details Body system
001 Sepsis Immune
Hypertensive emergency Circulatory
024 Acute respiratory failure with hypoxia Respiratory
026 Hypertensive emergency Circulatory
Acute respiratory failure with hypoxia Respiratory
COVID-negative pneumonia Respiratory
Hemoptysis Circulatory
040 COVID-19 and pleural effusion Respiratory
042 Cellulitis Integumentary
043 Ischemic stroke Circulatory
047 Seizure Nervous
Cavitary COVID-negative pneumonia Respiratory
Kidney transplant Renal
051 Acute gout flare-up Skeletal
057 Pneumonia due to COVID-19 Respiratory
062 Cellulitis from debridement Integumentary
Osteomyelitis of toe Skeletal
063 Multifocal COVID-negative pneumonia Respiratory
Renal hemophagocytic cyst Renal
079 Severe lower left extremity pain Muscular
085 Suspected COVID-negative pneumonia Respiratory
COPD exacerbation Respiratory
Chronic diastolic heart failure Circulatory
Sepsis Immune
Respiratory failure Respiratory
Sepsis from COVID-negative pneumonia Respiratory
Humerus fracture Skeletal
090 Worsening of anemia Circulatory
103 Hypoglycemia Circulatory
106 Severe sepsis Immune
Endocarditis Circulatory
113 Toe pain with gangrene Integumentary
Continued toe pain with gangrene Integumentary
114 Pulmonary hypertension Respiratory
Death (COVID-19) Respiratory
121 Gangrene and osteomyelitis Skeletal
Hypoglycemia Circulatory
135 COVID-19 Respiratory
Acute hypoxic respiratory failure Respiratory
138 COVID-19 Respiratory
145 Venous thromboembolism Circulatory
Death (sepsis) Immune
168 Acute metabolic encephalopathy Neurologic
Altered mental status Neurologic
Acute metabolic encephalopathy Neurologic
187 Hyperkalemia Renal
205 Foot wounds Integumentary
224 Abdominal pain Gastrointestinal
248 Femoral fracture after a fall Integumentary
Shortness of breath Respiratory
256 Death (cardiac arrest) Circulatory